prikaz prve stranice dokumenta Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
  Download
PDF 671.1 KB
Professional paper - Letter to the editor
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
European Respiratory Journal, 59 (2022), 5; 2200388. https://doi.org/10.1183/13993003.00388-2022
(Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS), Tuberculosis Network European Trials group (TBnet)) Guglielmetti, Lorenzo; Günther, Gunar; Leu, Claude; Cirillo, Daniela; Duarte, Raquel; Garcia-Basteiro, Alberto L.; Goletti, Delia; Janković, Mateja; Kuksa, Liga; Maurer, Florian P.; Méchaï, Frédéric; Tiberi, Simon; van Leth, Frank; Veziris, Nicolas; Lange, Christoph More authors...

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Guglielmetti, L., Günther, G., Leu, C., Cirillo, D., Duarte, R., Garcia Basteiro, A. L. ... Lange, C. (2022). Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. European Respiratory Journal, 59. (5). doi: 10.1183/13993003.00388-2022

Guglielmetti, Lorenzo, et al. "Rifapentine access in Europe: growing concerns over key tuberculosis treatment component." European Respiratory Journal, vol. 59, no. 5, 2022. https://doi.org/10.1183/13993003.00388-2022

Guglielmetti, Lorenzo, Gunar Günther, Claude Leu, Daniela Cirillo, Raquel Duarte, Alberto L. Garcia Basteiro, Delia Goletti, et al. "Rifapentine access in Europe: growing concerns over key tuberculosis treatment component." European Respiratory Journal 59, no. 5 (2022). https://doi.org/10.1183/13993003.00388-2022

Guglielmetti, L., et al. (2022) 'Rifapentine access in Europe: growing concerns over key tuberculosis treatment component', European Respiratory Journal, 59(5). doi: 10.1183/13993003.00388-2022

Guglielmetti L, Günther G, Leu C, Cirillo D, Duarte R, Garcia Basteiro AL, and sur.. Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. European Respiratory Journal [Internet]. 2022 May 19 [cited 2024 December 28];59(5). doi: 10.1183/13993003.00388-2022

L. Guglielmetti, et al., "Rifapentine access in Europe: growing concerns over key tuberculosis treatment component", European Respiratory Journal, vol. 59, no. 5, May 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:390162. [Accessed: 28 December 2024]

Metadata
Title (english)Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
AuthorLorenzo Guglielmetti
AuthorGunar Günther
AuthorClaude Leu
AuthorDaniela Cirillo
AuthorRaquel Duarte
AuthorAlberto L. Garcia-Basteiro
AuthorDelia Goletti
AuthorMateja Janković
AuthorLiga Kuksa
AuthorFlorian P. Maurer
AuthorFrédéric Méchaï
AuthorSimon Tiberi
AuthorFrank van Leth
AuthorNicolas Veziris
AuthorChristoph Lange
CollaborationStudy Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC)
CollaborationEuropean Society of Mycobacteriology (ESM)
CollaborationEuropean Respiratory Society (ERS)
CollaborationTuberculosis Network European Trials group (TBnet)
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
Lack of access to rifapentine in Europe denies patients optimal care for active tuberculosis and latent tuberculosis infection, and deprives healthcare providers of adequate tools to pursue tuberculosis control and elimination https://bit.ly/3jz85eh
Keywords (english)
Languageenglish
Publication typeProfessional paper - Letter to the editor
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleEuropean Respiratory Journal
Numberingvol. 59, no. 5, 2200388
p-ISSN0903-1936
e-ISSN1399-3003
DOIhttps://doi.org/10.1183/13993003.00388-2022
URN:NBNurn:nbn:hr:105:390162
Publication2022-05-19
Document URLhttp://erj.ersjournals.com/lookup/doi/10.1183/13993003.00388-2022
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) icon
Created on2022-12-15 10:40:56